Skip to Main Content

Paper Details

Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.
Am J Hum Genet
4
2021
Author NameAffiliation
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, University of Toronto
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, University of Toronto
Hoda Anton-CulverGenetic Epidemiology Research Institute, University of California Irvine
Hoda Anton-CulverGenetic Epidemiology Research Institute, University of California Irvine
Sabine BehrensGerman Cancer Research Center (DKFZ)
Javier Ben??tezSpanish National Cancer Research Centre (CNIO)
Qiuyin CaiVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Federico CanzianGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ), University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Christine L ClarkeWestmead Institute for Medical Research, University of Sydney
Christine L ClarkeWestmead Institute for Medical Research, University of Sydney
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Laure Dossus
Peter A FaschingComprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Germany David Geffen School of Medicine, University of California at Los Angeles
Jonine D FigueroaNational Cancer Institute, National Institutes of Health, The University of Edinburgh
Jonine D FigueroaNational Cancer Institute, National Institutes of Health, The University of Edinburgh
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Maya GhoussainiUniversity of Cambridge, Wellcome Sanger Institute
Graham G GilesThe University of Melbourne, School of Clinical Sciences at Monash Health, Monash University
Christopher A HaimanKeck School of Medicine, University of Southern California
Christopher A HaimanKeck School of Medicine, University of Southern California
Per HallKarolinska Institutet
Ming-Feng HouKaohsiung Municipal Hsiao-Kang Hospital
Esther M JohnStanford University School of Medicine, Stanford Cancer Institute
Rudolf KaaksGerman Cancer Research Center (DKFZ)
Peter KraftHarvard T.H. Chan School of Public Health
Peter KraftHarvard T.H. Chan School of Public Health
Vessela N KristensenUniversity of Oslo, Oslo University Hospital and University of Oslo
James V LaceyUSA City of Hope Comprehensive Cancer Center
James V LaceyUSA City of Hope Comprehensive Cancer Center
Diether LambrechtsVIB Center for Cancer Biology, University of Leuven
Loic Le MarchandUniversity of Hawaii Cancer Center
Jirong LongVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Jan LubinskiPomeranian Medical University
Jan LubinskiPomeranian Medical University
Siranoush ManoukianFondazione IRCCS Istituto Nazionale dei Tumori di Milano
Usha MenonInstitute of Clinical Trials & Methodology, University College London
Usha MenonInstitute of Clinical Trials & Methodology, University College London
Roger L MilneThe University of Melbourne, School of Clinical Sciences at Monash Health, Monash University
Janet E OlsonMayo Clinic
Xiao-Ou ShuVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Jennifer StoneThe University of Melbourne, University of Western Australia
Mary Beth TerryMailman School of Public Health, Columbia University
Chiu-Chen TsengKeck School of Medicine, University of Southern California
  • 1 - 50

Datasets